Continuous Tibial Nerve Block Versus Single Shot Tibial Nerve Block

A Randomized Comparison of a Continuous Posterior Tibial Nerve Block and Single Injection Posterior Tibial Nerve Block in Patients Undergoing Forefoot Surgery

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01555216

Enrollment

Registered

2012-03-15

Start date

2011-10-31

Completion date

2014-12-31

Last updated

2016-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Valgus

Keywords

Forefoot surgery

Brief summary

Foot surgery often causes severe and prolonged pain postoperatively. Prior methods of postoperative pain control included oral narcotics, single injection regional techniques and more recently continuous nerve catheters. Recent studies have demonstrated a benefit with continuous popliteal catheters when compared to single injection techniques in regards to postoperative pain control and patient satisfaction for foot surgeries. Nerve blocks in the popliteal fossa involve both the common peroneal nerve and the tibial nerve. The innervation to the plantar surface of the forefoot involves the tibial nerve and does not involve the peroneal nerve. The purpose of this study is to compare the continuous posterior tibial nerve catheter with a single injection posterior tibial nerve block when used as part of a surgical ankle block for forefoot surgery.

Interventions

DRUGSingle injection posterior tibial nerve block

5 ml of 0.5% ropivacaine

DRUGPosterior tibial nerve catheter

5ml bolus of 0.5% ropivacaine with 3 ml/h of 0.2% ropivacaine with a bolus every two hours

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Adult patients (18 to 65 years old) undergoing elective scheduled forefoot surgery (hallux valgus repair and metatarsal osteotomy).

Exclusion criteria

* Patient refusal to be included * Presence of language barrier that prohibits proper communication with patient * Under age of 18, * Pregnancy * History of allergy to local anesthetics or opioids * Presence of a progressive neurological deficit * Chronic opioid or drug abuse * Diabetes * Active infection in leg * Unstable cardiovascular, renal or hepatic disease, * Unwillingness to comply with follow up.

Design outcomes

Primary

Measure	Time frame	Description
Quality of recovery	Up to five days	Quality of recovery

Secondary

Measure	Time frame	Description
Pain control (pain score)	Up to 1 week	pain control (pain score) between groups
Opioid consumption	Up to 1 week	Opioid consumption
patient satisfaction	Up to 1 week	patient satisfaction with pain control

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026